Ciphergen Biosystems –

Palo Alto, Calif.

Went public 9/29/2000 at $16 per share

Filing Range: 5.5 mil. shares @ $14 to $16

Shares Outstanding: 25.1 mil. shares

Underwriters: SG Cowen Securities Corp./ING Barings/

UBS Warburg

Company Counsel: Wilson Sonsini Goodrich & Rosati

Manager Counsel: Brobeck Phleger & Harrison LLP

Auditor: Pricewaterhouse Coopers LLP

The Company:

Develops and manufactures protein discovery and characterization products. Ciphergen Biosystems’ ProteinChip System enables protein discovery, characterization and assay development to provide researchers with a better understanding of biological functions at the protein level. Protein characterization is the determination of the detailed identity of a protein, including its sequence as predicted by the corresponding gene and any chemical modifications introduced after the protein is produced.

Venture Backers:

Atlas Venture

MDS Discovery Venture Management Inc.

EuclidSR Partners

Cheng Xin Technology Development Corp.

Financing Rounds:

Number of Round Amt.

Round # Round Date Stage Investors ($ thousands)

1 07/01/1994 2 Early Stage 1524.0

2 07/01/1996 3 Early Stage 6588.0

3 04/01/1997 3 Expansion 4442.0

4 10/01/1998 4 Later Stage 13753.0

5 03/01/2000 6 Expansion 29000.0


(Data in $ millions)



Total Revenues: $5.0

Net Income: -7.9